Sponsored
by Biovian
Gene Therapy: Can CDMOs Solve the Manufacturing Bottleneck?
The gene therapy market is booming. Viral vectors, the key delivery systems for gene therapies,…
29/03/2022 - 7 minutes
Gene Therapy: A Rapidly Evolving Industry
As one of the biggest success stories of the 21st century, gene therapy is providing hope for treating diseases that once seemed incurable. Any genetic mutation causing disease could theoretically be fixed by inserting a new copy of the faulty gene. This means that gene therapy has the potential to treat some previously incurable conditions with a single dose.
By 2025, the FDA expects to approve between 10 and 20 gene therapies each year, and we are already seeing an increase in the number of approvals today. However, the field continues to face a number of obstacles ranging from safety concerns to manufacturing shortages. Read on to get the latest in the gene therapy field.
Show More
Gene Therapy Industry Report 2021
In this report, we take a closer look at the growing gene therapy market, current development and manufacturing challenges, and the exciting future ahead for this industry.
Go to ReportLatest Gene therapy Articles
Ilya Pharma Paves Way for Bacterial Gene Therapy with €8.5M Funding
Cell and gene therapies are taking off in a big way in Europe. As the…
23/03/2022 - 4 minutes
Startup Bags €50M Series A to Smash Gene Therapy Vector Limits
After closing Spain’s largest biopharma Series A round, the company SpliceBio has set its foundations…
16/02/2022 - 5 minutes
Two Gene Therapy Players Launch IPOs on Stormy Stock Market
After a drought of more than a year, the European gene therapy sector saw initial…
21/01/2022 - 4 minutes
Europe Trailed US Despite Record Gene and Cell Therapy Funding in 2021
Cell and gene therapy developers globally raised an all-time annual record in 2021. However, European…
14/01/2022 - 6 minutes
The Biggest European Biotech News of 2021
In spite of the challenges posed by the Covid-19 pandemic, the European biotech industry has…
22/12/2021 - 10 minutes
How Will We Be Treating Cystic Fibrosis 10 Years From Now?
Current treatments for cystic fibrosis are not suitable for all patients and have a limited…
22/11/2021 - 9 minutes
Sponsored
by Merck
Gene therapy: Making Rare Disease Therapies Less Rare
While individually uncommon, rare diseases collectively impact the lives of over 300 million people worldwide.…
15/11/2021 - 2 minutes
Sponsored
by Merck
The Evolving Role of Automation in Gene Therapy Manufacturing
Today, large-scale gene therapy manufacturing faces challenges such as mounting regulatory requirements and the need…
09/11/2021 - 7 minutes
Skilled Labor Shortages Impact Cell And Gene Therapy Manufacturing
Despite vast amounts of funding entering the cell and gene therapy field, the manufacture of…
04/11/2021 - 5 minutes
Sponsored
by OXGENE
Plasmids: How to Solve a Bottleneck in Scalable Gene Therapy Manufacturing?
As gene therapies become increasingly successful, companies are in a competitive race to deliver manufacturing…
26/10/2021 - 7 minutes
Sponsored
by Merck
How to Develop a Robust Viral Safety Strategy for Gene Therapies
Gene therapies offer a promising hope of cure against rare diseases and other diseases like…
06/10/2021 - 8 minutes
